Biological E. Limited

DCGI Approves Biological E’s 14-Valent Pneumococcal Conjugate Vaccine - Sakshi Post

Biological E’s 14-Valent Pneumococcal Conjugate Vaccine

Dec 16, 2022
Hyderabad: Hyderabad-based Pharmaceutical and Vaccine Company Biological E.
- Sakshi Post

Biological E To Invest Over Rs 1800 Crores In Hyderabad For Vaccines Manufacturing

Jul 21, 2022
Cementing Hyderabad’s position as “Vaccine Capital of the World”, Biological E has announced their expansion plans for investment of more than INR 1800 crores and employment creation of more than...
Biological E Launches Rs 300 Crore Plant In Hyderabad - Sakshi Post

Biological E Launches Rs 300 Crore Plant In Hyderabad

Feb 18, 2020
Pharmaceutical company Biological E. Limited on Monday launched its new plant, built with an investment of Rs. 300 crore at Genome Valley here.
Back to Top